Influence of FcgammaRIIA and MBL polymorphisms on severe acute respiratory syndrome.
Identifieur interne : 002655 ( PubMed/Checkpoint ); précédent : 002654; suivant : 002656Influence of FcgammaRIIA and MBL polymorphisms on severe acute respiratory syndrome.
Auteurs : F F Yuan [Australie] ; J. Tanner ; P K S. Chan ; S. Biffin ; W B Dyer ; A F Geczy ; J W Tang ; D S C. Hui ; J J Y. Sung ; J S SullivanSource :
- Tissue antigens [ 0001-2815 ] ; 2005.
Descripteurs français
- KwdFr :
- Adulte, Adulte d'âge moyen, Allèles, Antigènes CD (génétique), Antigènes CD (immunologie), Femelle, Fréquence d'allèle (génétique), Fréquence d'allèle (immunologie), Humains, Lectine liant le mannose (génétique), Lectine liant le mannose (immunologie), Mâle, Polymorphisme génétique (génétique), Polymorphisme génétique (immunologie), Récepteurs du fragment Fc des IgG (génétique), Récepteurs du fragment Fc des IgG (immunologie), Sujet âgé, Syndrome respiratoire aigu sévère (génétique), Syndrome respiratoire aigu sévère (immunologie), Syndrome respiratoire aigu sévère (mortalité), Virus du SRAS (immunologie), Études cas-témoins.
- MESH :
- génétique : Antigènes CD, Fréquence d'allèle, Lectine liant le mannose, Polymorphisme génétique, Récepteurs du fragment Fc des IgG, Syndrome respiratoire aigu sévère.
- immunologie : Antigènes CD, Fréquence d'allèle, Lectine liant le mannose, Polymorphisme génétique, Récepteurs du fragment Fc des IgG, Syndrome respiratoire aigu sévère, Virus du SRAS.
- mortalité : Syndrome respiratoire aigu sévère.
- Adulte, Adulte d'âge moyen, Allèles, Femelle, Humains, Mâle, Sujet âgé, Études cas-témoins.
English descriptors
- KwdEn :
- Adult, Aged, Alleles, Antigens, CD (genetics), Antigens, CD (immunology), Case-Control Studies, Female, Gene Frequency (genetics), Gene Frequency (immunology), Humans, Male, Mannose-Binding Lectin (genetics), Mannose-Binding Lectin (immunology), Middle Aged, Polymorphism, Genetic (genetics), Polymorphism, Genetic (immunology), Receptors, IgG (genetics), Receptors, IgG (immunology), SARS Virus (immunology), Severe Acute Respiratory Syndrome (genetics), Severe Acute Respiratory Syndrome (immunology), Severe Acute Respiratory Syndrome (mortality).
- MESH :
- chemical , genetics : Antigens, CD, Mannose-Binding Lectin, Receptors, IgG.
- chemical , immunology : Antigens, CD, Mannose-Binding Lectin, Receptors, IgG.
- genetics : Gene Frequency, Polymorphism, Genetic, Severe Acute Respiratory Syndrome.
- immunology : Gene Frequency, Polymorphism, Genetic, SARS Virus, Severe Acute Respiratory Syndrome.
- mortality : Severe Acute Respiratory Syndrome.
- Adult, Aged, Alleles, Case-Control Studies, Female, Humans, Male, Middle Aged.
Abstract
Polymorphisms of human Fc gamma-receptor IIA (FcgammaRIIA) and mannose-binding lectin (MBL) genes have been associated with susceptibility to or severity of some infectious diseases. In order to investigate whether these genetic factors might influence susceptibility to infection with the severe acute respiratory syndrome-associated coronavirus (SARS-Cov) as well as the course and severity of the infection, we evaluated polymorphisms of FcgammaRIIA and MBL genes in DNA samples from a group of approximately 180 people from Hong Kong who were infected with SARS-Cov. These included 132 patients who had moderate course of SARS infection (home subgroup), 26 patients with a severe course requiring treatment in an intensive care ward (ICU subgroup) and a subgroup of 22 patients who died from SARS (deceased subgroup). A total of 200 normal blood donors from the same region were used as controls. A significant association was found between the FcgammaRIIA-R/R131 genotype and a severe course of SARS, with higher frequency of homozygosity for FcgammaRIIA-R/R131 in the ICU subgroup of SARS patients when compared with controls (P=0.03; odds ratio: 3.2; 95% confidence interval: 1.1-9.1). In comparison with controls, a significant difference in linear trend distribution of FcgammaRIIA genotypes was seen among the severe SARS patients (ICU and deceased subgroups) without co-morbidity, and the incidence of FcgammaRIIA-H/H131 was lower in these patients as well. There were no significant differences in MBL genotypes and allele frequencies among SARS patients and controls. The study reveals that in addition to age and co-morbidity, FcgammaRIIA polymorphism of individuals may also influence outcome after infection with the SARS-Cov.
DOI: 10.1111/j.1399-0039.2005.00476.x
PubMed: 16185324
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:16185324Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Influence of FcgammaRIIA and MBL polymorphisms on severe acute respiratory syndrome.</title><author><name sortKey="Yuan, F F" sort="Yuan, F F" uniqKey="Yuan F" first="F F" last="Yuan">F F Yuan</name><affiliation wicri:level="1"><nlm:affiliation>Australian Red Cross Blood Service-Endeavour, Sydney, NSW, Australia. fyuan@arcbs.redcross.org.au</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Australian Red Cross Blood Service-Endeavour, Sydney, NSW</wicri:regionArea><wicri:noRegion>NSW</wicri:noRegion></affiliation></author><author><name sortKey="Tanner, J" sort="Tanner, J" uniqKey="Tanner J" first="J" last="Tanner">J. Tanner</name></author><author><name sortKey="Chan, P K S" sort="Chan, P K S" uniqKey="Chan P" first="P K S" last="Chan">P K S. Chan</name></author><author><name sortKey="Biffin, S" sort="Biffin, S" uniqKey="Biffin S" first="S" last="Biffin">S. Biffin</name></author><author><name sortKey="Dyer, W B" sort="Dyer, W B" uniqKey="Dyer W" first="W B" last="Dyer">W B Dyer</name></author><author><name sortKey="Geczy, A F" sort="Geczy, A F" uniqKey="Geczy A" first="A F" last="Geczy">A F Geczy</name></author><author><name sortKey="Tang, J W" sort="Tang, J W" uniqKey="Tang J" first="J W" last="Tang">J W Tang</name></author><author><name sortKey="Hui, D S C" sort="Hui, D S C" uniqKey="Hui D" first="D S C" last="Hui">D S C. Hui</name></author><author><name sortKey="Sung, J J Y" sort="Sung, J J Y" uniqKey="Sung J" first="J J Y" last="Sung">J J Y. Sung</name></author><author><name sortKey="Sullivan, J S" sort="Sullivan, J S" uniqKey="Sullivan J" first="J S" last="Sullivan">J S Sullivan</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2005">2005</date><idno type="RBID">pubmed:16185324</idno><idno type="pmid">16185324</idno><idno type="doi">10.1111/j.1399-0039.2005.00476.x</idno><idno type="wicri:Area/PubMed/Corpus">002525</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002525</idno><idno type="wicri:Area/PubMed/Curation">002525</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002525</idno><idno type="wicri:Area/PubMed/Checkpoint">002655</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002655</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Influence of FcgammaRIIA and MBL polymorphisms on severe acute respiratory syndrome.</title><author><name sortKey="Yuan, F F" sort="Yuan, F F" uniqKey="Yuan F" first="F F" last="Yuan">F F Yuan</name><affiliation wicri:level="1"><nlm:affiliation>Australian Red Cross Blood Service-Endeavour, Sydney, NSW, Australia. fyuan@arcbs.redcross.org.au</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Australian Red Cross Blood Service-Endeavour, Sydney, NSW</wicri:regionArea><wicri:noRegion>NSW</wicri:noRegion></affiliation></author><author><name sortKey="Tanner, J" sort="Tanner, J" uniqKey="Tanner J" first="J" last="Tanner">J. Tanner</name></author><author><name sortKey="Chan, P K S" sort="Chan, P K S" uniqKey="Chan P" first="P K S" last="Chan">P K S. Chan</name></author><author><name sortKey="Biffin, S" sort="Biffin, S" uniqKey="Biffin S" first="S" last="Biffin">S. Biffin</name></author><author><name sortKey="Dyer, W B" sort="Dyer, W B" uniqKey="Dyer W" first="W B" last="Dyer">W B Dyer</name></author><author><name sortKey="Geczy, A F" sort="Geczy, A F" uniqKey="Geczy A" first="A F" last="Geczy">A F Geczy</name></author><author><name sortKey="Tang, J W" sort="Tang, J W" uniqKey="Tang J" first="J W" last="Tang">J W Tang</name></author><author><name sortKey="Hui, D S C" sort="Hui, D S C" uniqKey="Hui D" first="D S C" last="Hui">D S C. Hui</name></author><author><name sortKey="Sung, J J Y" sort="Sung, J J Y" uniqKey="Sung J" first="J J Y" last="Sung">J J Y. Sung</name></author><author><name sortKey="Sullivan, J S" sort="Sullivan, J S" uniqKey="Sullivan J" first="J S" last="Sullivan">J S Sullivan</name></author></analytic><series><title level="j">Tissue antigens</title><idno type="ISSN">0001-2815</idno><imprint><date when="2005" type="published">2005</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Aged</term><term>Alleles</term><term>Antigens, CD (genetics)</term><term>Antigens, CD (immunology)</term><term>Case-Control Studies</term><term>Female</term><term>Gene Frequency (genetics)</term><term>Gene Frequency (immunology)</term><term>Humans</term><term>Male</term><term>Mannose-Binding Lectin (genetics)</term><term>Mannose-Binding Lectin (immunology)</term><term>Middle Aged</term><term>Polymorphism, Genetic (genetics)</term><term>Polymorphism, Genetic (immunology)</term><term>Receptors, IgG (genetics)</term><term>Receptors, IgG (immunology)</term><term>SARS Virus (immunology)</term><term>Severe Acute Respiratory Syndrome (genetics)</term><term>Severe Acute Respiratory Syndrome (immunology)</term><term>Severe Acute Respiratory Syndrome (mortality)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Allèles</term><term>Antigènes CD (génétique)</term><term>Antigènes CD (immunologie)</term><term>Femelle</term><term>Fréquence d'allèle (génétique)</term><term>Fréquence d'allèle (immunologie)</term><term>Humains</term><term>Lectine liant le mannose (génétique)</term><term>Lectine liant le mannose (immunologie)</term><term>Mâle</term><term>Polymorphisme génétique (génétique)</term><term>Polymorphisme génétique (immunologie)</term><term>Récepteurs du fragment Fc des IgG (génétique)</term><term>Récepteurs du fragment Fc des IgG (immunologie)</term><term>Sujet âgé</term><term>Syndrome respiratoire aigu sévère (génétique)</term><term>Syndrome respiratoire aigu sévère (immunologie)</term><term>Syndrome respiratoire aigu sévère (mortalité)</term><term>Virus du SRAS (immunologie)</term><term>Études cas-témoins</term></keywords><keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Antigens, CD</term><term>Mannose-Binding Lectin</term><term>Receptors, IgG</term></keywords><keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Antigens, CD</term><term>Mannose-Binding Lectin</term><term>Receptors, IgG</term></keywords><keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Gene Frequency</term><term>Polymorphism, Genetic</term><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Antigènes CD</term><term>Fréquence d'allèle</term><term>Lectine liant le mannose</term><term>Polymorphisme génétique</term><term>Récepteurs du fragment Fc des IgG</term><term>Syndrome respiratoire aigu sévère</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Antigènes CD</term><term>Fréquence d'allèle</term><term>Lectine liant le mannose</term><term>Polymorphisme génétique</term><term>Récepteurs du fragment Fc des IgG</term><term>Syndrome respiratoire aigu sévère</term><term>Virus du SRAS</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Gene Frequency</term><term>Polymorphism, Genetic</term><term>SARS Virus</term><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="mortalité" xml:lang="fr"><term>Syndrome respiratoire aigu sévère</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Alleles</term><term>Case-Control Studies</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Allèles</term><term>Femelle</term><term>Humains</term><term>Mâle</term><term>Sujet âgé</term><term>Études cas-témoins</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Polymorphisms of human Fc gamma-receptor IIA (FcgammaRIIA) and mannose-binding lectin (MBL) genes have been associated with susceptibility to or severity of some infectious diseases. In order to investigate whether these genetic factors might influence susceptibility to infection with the severe acute respiratory syndrome-associated coronavirus (SARS-Cov) as well as the course and severity of the infection, we evaluated polymorphisms of FcgammaRIIA and MBL genes in DNA samples from a group of approximately 180 people from Hong Kong who were infected with SARS-Cov. These included 132 patients who had moderate course of SARS infection (home subgroup), 26 patients with a severe course requiring treatment in an intensive care ward (ICU subgroup) and a subgroup of 22 patients who died from SARS (deceased subgroup). A total of 200 normal blood donors from the same region were used as controls. A significant association was found between the FcgammaRIIA-R/R131 genotype and a severe course of SARS, with higher frequency of homozygosity for FcgammaRIIA-R/R131 in the ICU subgroup of SARS patients when compared with controls (P=0.03; odds ratio: 3.2; 95% confidence interval: 1.1-9.1). In comparison with controls, a significant difference in linear trend distribution of FcgammaRIIA genotypes was seen among the severe SARS patients (ICU and deceased subgroups) without co-morbidity, and the incidence of FcgammaRIIA-H/H131 was lower in these patients as well. There were no significant differences in MBL genotypes and allele frequencies among SARS patients and controls. The study reveals that in addition to age and co-morbidity, FcgammaRIIA polymorphism of individuals may also influence outcome after infection with the SARS-Cov.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">16185324</PMID><DateCompleted><Year>2005</Year><Month>12</Month><Day>20</Day></DateCompleted><DateRevised><Year>2005</Year><Month>09</Month><Day>27</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0001-2815</ISSN><JournalIssue CitedMedium="Print"><Volume>66</Volume><Issue>4</Issue><PubDate><Year>2005</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Tissue antigens</Title><ISOAbbreviation>Tissue Antigens</ISOAbbreviation></Journal><ArticleTitle>Influence of FcgammaRIIA and MBL polymorphisms on severe acute respiratory syndrome.</ArticleTitle><Pagination><MedlinePgn>291-6</MedlinePgn></Pagination><Abstract><AbstractText>Polymorphisms of human Fc gamma-receptor IIA (FcgammaRIIA) and mannose-binding lectin (MBL) genes have been associated with susceptibility to or severity of some infectious diseases. In order to investigate whether these genetic factors might influence susceptibility to infection with the severe acute respiratory syndrome-associated coronavirus (SARS-Cov) as well as the course and severity of the infection, we evaluated polymorphisms of FcgammaRIIA and MBL genes in DNA samples from a group of approximately 180 people from Hong Kong who were infected with SARS-Cov. These included 132 patients who had moderate course of SARS infection (home subgroup), 26 patients with a severe course requiring treatment in an intensive care ward (ICU subgroup) and a subgroup of 22 patients who died from SARS (deceased subgroup). A total of 200 normal blood donors from the same region were used as controls. A significant association was found between the FcgammaRIIA-R/R131 genotype and a severe course of SARS, with higher frequency of homozygosity for FcgammaRIIA-R/R131 in the ICU subgroup of SARS patients when compared with controls (P=0.03; odds ratio: 3.2; 95% confidence interval: 1.1-9.1). In comparison with controls, a significant difference in linear trend distribution of FcgammaRIIA genotypes was seen among the severe SARS patients (ICU and deceased subgroups) without co-morbidity, and the incidence of FcgammaRIIA-H/H131 was lower in these patients as well. There were no significant differences in MBL genotypes and allele frequencies among SARS patients and controls. The study reveals that in addition to age and co-morbidity, FcgammaRIIA polymorphism of individuals may also influence outcome after infection with the SARS-Cov.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>F F</ForeName><Initials>FF</Initials><AffiliationInfo><Affiliation>Australian Red Cross Blood Service-Endeavour, Sydney, NSW, Australia. fyuan@arcbs.redcross.org.au</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tanner</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>P K S</ForeName><Initials>PK</Initials></Author><Author ValidYN="Y"><LastName>Biffin</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Dyer</LastName><ForeName>W B</ForeName><Initials>WB</Initials></Author><Author ValidYN="Y"><LastName>Geczy</LastName><ForeName>A F</ForeName><Initials>AF</Initials></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>J W</ForeName><Initials>JW</Initials></Author><Author ValidYN="Y"><LastName>Hui</LastName><ForeName>D S C</ForeName><Initials>DS</Initials></Author><Author ValidYN="Y"><LastName>Sung</LastName><ForeName>J J Y</ForeName><Initials>JJ</Initials></Author><Author ValidYN="Y"><LastName>Sullivan</LastName><ForeName>J S</ForeName><Initials>JS</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Tissue Antigens</MedlineTA><NlmUniqueID>0331072</NlmUniqueID><ISSNLinking>0001-2815</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015703">Antigens, CD</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C080568">Fc gamma receptor IIA</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D037601">Mannose-Binding Lectin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017452">Receptors, IgG</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000483" MajorTopicYN="Y">Alleles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015703" MajorTopicYN="N">Antigens, CD</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005787" MajorTopicYN="N">Gene Frequency</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D037601" MajorTopicYN="N">Mannose-Binding Lectin</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011110" MajorTopicYN="N">Polymorphism, Genetic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017452" MajorTopicYN="N">Receptors, IgG</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045473" MajorTopicYN="N">SARS Virus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045169" MajorTopicYN="N">Severe Acute Respiratory Syndrome</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2005</Year><Month>9</Month><Day>28</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2005</Year><Month>12</Month><Day>21</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2005</Year><Month>9</Month><Day>28</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">16185324</ArticleId><ArticleId IdType="pii">TAN476</ArticleId><ArticleId IdType="doi">10.1111/j.1399-0039.2005.00476.x</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Australie</li></country></list><tree><noCountry><name sortKey="Biffin, S" sort="Biffin, S" uniqKey="Biffin S" first="S" last="Biffin">S. Biffin</name><name sortKey="Chan, P K S" sort="Chan, P K S" uniqKey="Chan P" first="P K S" last="Chan">P K S. Chan</name><name sortKey="Dyer, W B" sort="Dyer, W B" uniqKey="Dyer W" first="W B" last="Dyer">W B Dyer</name><name sortKey="Geczy, A F" sort="Geczy, A F" uniqKey="Geczy A" first="A F" last="Geczy">A F Geczy</name><name sortKey="Hui, D S C" sort="Hui, D S C" uniqKey="Hui D" first="D S C" last="Hui">D S C. Hui</name><name sortKey="Sullivan, J S" sort="Sullivan, J S" uniqKey="Sullivan J" first="J S" last="Sullivan">J S Sullivan</name><name sortKey="Sung, J J Y" sort="Sung, J J Y" uniqKey="Sung J" first="J J Y" last="Sung">J J Y. Sung</name><name sortKey="Tang, J W" sort="Tang, J W" uniqKey="Tang J" first="J W" last="Tang">J W Tang</name><name sortKey="Tanner, J" sort="Tanner, J" uniqKey="Tanner J" first="J" last="Tanner">J. Tanner</name></noCountry><country name="Australie"><noRegion><name sortKey="Yuan, F F" sort="Yuan, F F" uniqKey="Yuan F" first="F F" last="Yuan">F F Yuan</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002655 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 002655 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:16185324
|texte= Influence of FcgammaRIIA and MBL polymorphisms on severe acute respiratory syndrome.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:16185324" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |